Editor`s Corner

Editor`s Corner

ASH Clinical News’ Editor-in-Chief and Associate Editors offer their perspective on current topics in hematology and health care. The content of the Editor’s Corner is the opinion of the author and does not represent the official position of the American Society of Hematology unless so stated. Have a comment about these editorials? Let us know what you think; we welcome your feedback. Email the editor at [email protected].

Contract Research Agonizations

After years spent as an investigator on countless hematology and cancer clinical trials, all initiated with the noble intent of improving my patients’ lives...

Molecular Stamp Collecting

The great experimental physicist Ernest Rutherford (1871-1937) provocatively claimed, “All science is either physics … or stamp collecting.” Lord Rutherford intended his cocky quip as...

Letter From a Cleveland Jail to the ABIM: Patient Practicum

Dear American Board of Internal Medicine (ABIM): Writing to you, as usual, from behind the bars of emotional turmoil, political dissonance, and unresolved neuroses regarding...

Learning to Love Your Genome

The daily circus of recent world events has left me wondering whether it is truly plausible that I share a genome with the other...

Microphone Moment

Entering Monday’s oral abstract session at the 2016 ASH Annual Meeting, my goals were twofold: to see some great science that may influence how...

Making a Hematology Wishlist, and Checking it Twice

Happy New Year! Can you believe it’s 2017 already? Another holiday season passed, another calendar page flipped, another year gone by. I thought that I...

So You Say You Want To Be A Clinical Researcher?

Perhaps you’ve just finished your hematology/oncology fellowship a year or two ago. Or you’re still a fellow and, having completed that intensive first year...

On Eating Bone Marrow

The first time I ate bone marrow was, fittingly, shortly after I spoke on marrow failure at a conference in Milan, where osso bucco...

A Primer on Email Etiquette

Every day, more than 200 billion emails are sent and received, for an average of 122 emails sent and received, per user, in a...

The Decline and Fall of Cytotoxic Chemotherapy

Here, Dr. Stewart gives his take on whether cytotoxic chemotherapy should be declared a thing of the past. As ward rounds ended last Saturday, a...
Advertisement

Current Issue

July 2017, Volume 3, Issue 8

This issue features an interview with the FDA's Richard Pazdur, highlights from the 2017 ASCO Annual Meeting, a debate about minimal residual disease in myeloma, and more.